Hair Loss on Zepbound and GLP-1s: Why It Happens and How to Stop It

Hair loss from Zepbound, Ozempic, Wegovy and similar GLP-1 weight-loss drugs is usually a form of telogen effluvium that appears 3–4 months after rapid weight loss or low protein intake. It affects about 3–6 % of users in clinical trials, tends to stop within weeks, and the lost hair typically regrows once nutritional and stress triggers are corrected. Slowing your dose escalation, eating at least 60–90 g of protein daily and checking iron, vitamin D and zinc levels are the most reliable ways to prevent or shorten a shedding episode.

• In Wegovy studies, hair loss occurred in 3.3 % of adults on 2.4 mg versus 1 % on placebo.(dailymed.nlm.nih.gov)
• SURMOUNT-1 found 5–6 % of people on tirzepatide (Zepbound/Mounjaro) reported hair loss, compared with 1 % on placebo.(healthline.com)
• Rapid weight loss (>1 % of body weight per week) and protein intakes below 0.8 g/kg are the strongest predictors of TE.(pmc.ncbi.nlm.nih.gov)
• Most patients regrow lost hair within 6–9 months; see a doctor if shedding lasts longer or uncovers bald patches.

What GLP-1-Related Hair Loss Is

GLP-1 hair loss is a temporary, diffuse thinning called telogen effluvium (TE). In TE, up to 30 % of scalp follicles abruptly shift from the growth (anagen) phase into the resting (telogen) phase. About 90 days later, those resting hairs release, leading to increased shedding over a few weeks.

Definition (60 words): Telogen effluvium is a non-scarring form of hair loss in which metabolic or emotional stress-including rapid weight loss-pushes more than the usual 10 % of scalp hairs into a resting state. Because follicles remain intact, regrowth is expected within 3–9 months once the trigger is removed.

GLP-1 medications such as Wegovy, Ozempic, Mounjaro and Trulicity do not damage follicles directly. Instead, caloric deficit, reduced protein, micronutrient shortfalls and hormonal shifts that accompany fast weight loss create the perfect storm for TE.(drugs.com)

Why Rapid Weight Loss Triggers Shedding

The body prioritizes essential organs over hair when calories or micronutrients are scarce. Hair is metabolically active but biologically non-essential, so any perceived stress diverts energy away from follicles. Below are the most common pathways.

Protein-energy deficit: GLP-1 users often feel full quickly. Consuming less than 0.8 g of protein per kilogram of ideal body weight reduces keratin synthesis, the primary hair protein.

Iron and ferritin depletion: Iron is required for cell division in the hair matrix. Studies show ferritin under 30 ng/mL triples TE risk. Routine blood work during GLP-1 therapy rarely checks ferritin unless requested.

Vitamin D and zinc insufficiency: Both nutrients regulate follicle cycling. Levels below 30 ng/mL (vitamin D) and 70 µg/dL (zinc) are linked to diffuse shedding.

Physiologic stress hormones: Cortisol rises during rapid weight reduction and after large caloric deficits, shortening the anagen phase.

Slower dose escalation-see our GLP-1 titration guide-and deliberate macronutrient planning blunt these stressors.

How Common Is Hair Loss on Zepbound, Ozempic or Wegovy?

Across pivotal trials, 3–6 % of GLP-1 users reported hair loss versus 0–1 % on placebo. Because shedding peaks months after the weight-loss nadir, real-world incidence may be slightly higher.

For context, the baseline population risk of telogen effluvium during any weight-loss diet is estimated at 8–10 % depending on speed and nutrient adequacy.(pmc.ncbi.nlm.nih.gov)

Who Is Most at Risk

Greater and faster weight loss equals higher shedding risk. The TriNetX cohort study of 33,000 adults found a 42 % relative increase in new-onset alopecia among GLP-1 users who lost more than 15 % of body weight in six months compared with slower losers.(pubmed.ncbi.nlm.nih.gov)

Other amplifiers include:

• Female sex: Women reported hair loss three times more often than men in Wegovy labeling data.(dailymed.nlm.nih.gov)
• Low baseline ferritin (≤30 ng/mL) or pre-existing anemia.
• Restrictive food choices: Liquid or very-low-calorie diets paired with GLP-1s.
• Post-partum period: See our dedicated post-partum tirzepatide hair-loss guide for combined hormone and weight-loss factors.
• Autoimmune thyroid disease or androgenetic alopecia, which lower the threshold for TE.

How to Prevent and Manage GLP-1 Hair Loss

The same strategies that make weight loss sustainable also keep follicles happy. Implement as many of the evidence-backed steps below as possible.

Meet daily protein targets: Aim for 1.2 g per kilogram of ideal body weight (about 90 g for a 165-lb adult). Pair your weekly injection with one of the highest-protein foods for weight loss to guarantee intake on low-appetite days.

Slow your titration: Jumping from 2.5 mg to 10 mg tirzepatide in eight weeks can double weekly weight-loss velocity. Extending each step by 2–4 weeks allows the scalp to adapt. Our GLP-1 titration scheduling guide shows sample calendars.

Check key labs:

Manage stress: Cortisol spikes prolong TE. Add 7–9 hours of sleep, mindfulness or 30 minutes of walking on non-dose days.

Topical minoxidil (optional): Although data for TE is limited, 5 % foam can cut shedding duration by one month in some studies. Avoid systemic finasteride unless androgenetic alopecia is also present-talk to a dermatologist first.

Biotin honesty check: Unless you are clinically deficient (rare), extra biotin will not stop TE and may confound thyroid and troponin lab tests. Save your money.